Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Value of Most Post-Traumatic Stress Treatments 'Uncertain'


Related Encyclopedia
 border=
Animal Bites
Anterior Cruciate Ligament Repair
Arthritis
Arthroscopy & Arthroscopic Surgery
More...

Related Healthscout Videos
 border=
Body Dysmorphic Disorder- A Serious Disease
Bioengineering versus Avian-Based HA?
What is Hyaluronic Acid?
Treatment Options for OA
More...

Related Drug Information
 border=
Adderal XR
Concerta
Effexor XR
Paxil
More...

Related News Articles
 border=
Fliers Can Keep Blood Clots at Bay
Health Tip: Coping With Epilepsy
Older Diabetics With Depression Face Higher Death Rate
Gene Variation Found in Boys With Delinquent Peers
More...


Page:  << Prev | 1 | 2 | 3 | Next >>

The Veterans Administration does have PTSD clinical practice guidelines in place, and they were last revised in 2004, Berg said. Any changes in those guidelines would not only affect veterans suffering from the condition, but a much wider population of patients. According to the experts, seven percent of Americans -- about 20 million people -- can expect to experience some form of PTSD during their lifetime.

In their review of the data, the IOM researchers pored through 53 trials investigating the effectiveness of medications against PTSD, including anticonvulsants, selective serotonin reuptake inhibitors (SSRIs) antidepressants (which include drugs such as Celexa, Paxil, Prozac and Zoloft), monoamine oxidase inhibitors, and certain antipsychotics.

They also looked at 37 studies that focused on the use of psychotherapies against PTSD. Those approaches included exposure therapy, cognitive therapy, coping skills training, and hypnosis.

Text Continues Below



Only studies involving exposure psychotherapy provided enough quality evidence to support the claim that it can ease PTSD, the researchers said.

All of the other pharmaceutical or behavioral treatments failed to reach that threshold, leaving the IOM team uncertain as to whether or not the therapies might be effective.

Much of that uncertainty was due to a preponderance of poorly conducted or incomplete trials, the experts said.

For example, many studies had participant dropout rates between 20 percent and 50 percent, making it nearly impossible for researchers to draw reliable conclusions.

In other cases, investigators weren't "blinded" as to which patients were getting a particular treatment or not, allowing bias to potentially creep into the results.

Furthermore, "the majority of the drug studies have been funded by the pharmaceutical manufacturers, and the majority of the psychotherapy studies have been conducted by the individuals who developed the techniques, or by their close collaborators," Berg noted. To help avoid bias, "We recommend that a broader range of investigators be supported to conduct studies that will replicate and confirm earlier studies," he said.

Page:  << Prev | 1 | 2 | 3 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 10/18/2007

Related Links
 border=
From Healthscout's partner site on anxiety, AnxietyConnection.com
Learn about types of anxiety medication.
What are anxiety treatment options?
Learn to cope with anxiety panic attacks.





SOURCES: Charles Goodstein, M.D., clinical professor, psychiatry, New York University School of Medicine, New York City; Oct. 18, 2007, Institute of Medicine teleconference with Alfred Berg, M.D., professor, family medicine, University of Washington School of Medicine, Seattle; and David Matchar, director of the Center for Clinical Health Policy Research, and professor, medicine, Duke University Medical Center, Durham, N.C.


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map